We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 0.14% | 35.45 | 35.25 | 36.15 | 35.45 | 35.45 | 35.45 | 38,157 | 08:12:44 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -18.27 | 106.6M |
TIDMFUM
RNS Number : 2633P
Futura Medical PLC
25 May 2018
25 May 2018
Futura Medical plc
("Futura" or "the Company")
Application for Block Listing
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology today announces that an application has been made to the London Stock Exchange to extend its block listings of securities by a total of 1,190,000 ordinary shares of 0.2 pence each (the "New Ordinary Shares") which may arise pursuant to the exercise of options under the Company's Unapproved Share Option Scheme and its EMI Share Option Scheme.
It is expected that admission will become effective on or around 30 May 2018 ("Admission"). Following Admission, the Company will notify its Schedule Six (block listing interim review) update for the period from 25 November 2017 to 30 May 2018.
Any New Ordinary Shares issued will be credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares of the Company.
For further information please contact:
Futura Medical plc James Barder, Chief Executive Tel: +44 (0) 1483 685 670 Email to: james.barder@futuramedical.com www.futuramedical.com N+1 Singer (Nominated Adviser and Broker) Aubrey Powell / Liz Yong Tel:+44 (0) 20 7496 Corporate Finance 3000 For media enquiries please contact: Buchanan Mark Court / Sophie Cowles Tel: +44 (0) 20 7466 / Stephanie Watson 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ALSFMGZKNDVGRZM
(END) Dow Jones Newswires
May 25, 2018 02:01 ET (06:01 GMT)
1 Year Futura Medical Chart |
1 Month Futura Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions